| |
As
a focused fund, NeuroVentures investment advantage is based on its
focus, expertise, and extensive contacts in the medical, scientific
and venture capital communities. We leverage these resources and
capabilities to identify the most promising new companies. In addition,
we look for opportunities where we can contribute more than capital.
Our
strategy is to target investments in the range of $200,000 to $2,000,000.
We are looking to diversify in the following three ways:
1.
Development stage (discovery, development, market)
2.
Company type (biopharmaceutical, device, diagnostic, other)
3.
Market focus (neurodegeneration, pain, stroke, cancer, etc.)
We
are committed to taking leading roles with portfolio companies and
providing time, expertise, and contacts to assist our companies
in the successful formation, funding and execution of their business
strategies. We believe this hands-on approach has helped us solidify
our reputation as valued investors both with our portfolio companies
and other venture investors.
We
are actively seeking investment opportunities that meet the following
investment criteria:
- Proven
management team
- Products
that address the mechanism of disease or dramatically impact patient
outcomes
- Products
with market potential > $100 million
- Strong
intellectual property position and competitive advantage
- Well-defined
regulatory and reimbursement strategy
- Milestone-driven
development strategy with focus on successful follow-on financings
- Clear
exit strategy with multiple options
|
